• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢功能障碍相关脂肪性肝病在肠道各区域表现出性别特异性的微生物异质性。

Metabolic dysfunction-associated steatotic liver disease exhibits sex-specific microbial heterogeneity within intestinal compartments.

作者信息

Pirola Carlos Jose, Landa Maria Silvina, Schuman Mariano, García Silvia Inés, Salatino Adrian, Sookoian Silvia

机构信息

Systems Biology of Complex Diseases, Translational Research in Health Center (CENITRES). Maimónides University, Buenos Aires, Argentin.

National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina.

出版信息

Clin Mol Hepatol. 2025 Jan;31(1):179-195. doi: 10.3350/cmh.2024.0359. Epub 2024 Oct 11.

DOI:10.3350/cmh.2024.0359
PMID:39391907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11791572/
Abstract

BACKGROUND/AIMS: Evidence suggests that the gastrointestinal microbiome plays a significant role in the biology of metabolic dysfunction-associated steatotic liver disease (MASLD). However, it remains unclear whether disparities in the gut microbiome across intestinal tissular compartments between the sexes lead to MASLD pathogenesis.

METHODS

Sex-specific analyses of microbiome composition in two anatomically distinct regions of the gut, the small intestine and colon, were performed using an experimental model of MASLD. The study involved male and female spontaneously hypertensive rats and the Wistar-Kyoto control rat strain, which were fed either a standard chow diet or a high-fat diet for 12 weeks to induce MASLD (12 rats per group). High-throughput 16S sequencing was used for microbiome analysis.

RESULTS

There were significant differences in the overall microbiome composition of male and female rats with MASLD, including variations in topographical gut regions. The beta diversity of the jejunal and colon microbiomes was higher in female rats than in male rats (PERMANOVA p-value=0.001). Sex-specific analysis and discriminant features using LEfSe showed considerable variation in bacterial abundance, along with distinct functional properties, in the jejunum and colon of animals with MASLD. Significantly elevated levels of lipopolysaccharide and protein expression of Toll-like receptor 4 were observed in the livers of male rats with MASLD compared with their female counterparts.

CONCLUSION

This study uncovered sexual dimorphism in the gut microbiome of MASLD and identified microbial heterogeneity within intestinal compartments. Insights into sex-specific variations in gut microbiome composition could facilitate customised treatment strategies.

摘要

背景/目的:有证据表明,胃肠道微生物群在代谢功能障碍相关脂肪性肝病(MASLD)的生物学过程中起重要作用。然而,性别之间肠道组织各部分的肠道微生物群差异是否会导致MASLD发病仍不清楚。

方法

使用MASLD实验模型,对肠道两个解剖学上不同区域(小肠和结肠)的微生物群组成进行性别特异性分析。该研究涉及雄性和雌性自发性高血压大鼠以及Wistar-Kyoto对照大鼠品系,将它们分别喂食标准饲料或高脂饲料12周以诱导MASLD(每组12只大鼠)。采用高通量16S测序进行微生物群分析。

结果

患有MASLD的雄性和雌性大鼠的整体微生物群组成存在显著差异,包括肠道不同区域的变化。雌性大鼠空肠和结肠微生物群的β多样性高于雄性大鼠(PERMANOVA p值=0.001)。使用LEfSe进行的性别特异性分析和判别特征显示,患有MASLD的动物空肠和结肠中的细菌丰度存在相当大的差异,以及不同的功能特性。与雌性MASLD大鼠相比,雄性MASLD大鼠肝脏中的脂多糖水平和Toll样受体4的蛋白表达显著升高。

结论

本研究揭示了MASLD肠道微生物群中的性别二态性,并确定了肠道各部分内的微生物异质性。对肠道微生物群组成中性别特异性差异的深入了解有助于制定个性化治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896d/11791572/9990e840e4ed/cmh-2024-0359f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896d/11791572/a681105883f4/cmh-2024-0359f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896d/11791572/e5631545b77b/cmh-2024-0359f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896d/11791572/bd37e33c7eff/cmh-2024-0359f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896d/11791572/4cb504e26474/cmh-2024-0359f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896d/11791572/1c045bb01298/cmh-2024-0359f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896d/11791572/75e669be69c4/cmh-2024-0359f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896d/11791572/5d94ad2556eb/cmh-2024-0359f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896d/11791572/9990e840e4ed/cmh-2024-0359f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896d/11791572/a681105883f4/cmh-2024-0359f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896d/11791572/e5631545b77b/cmh-2024-0359f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896d/11791572/bd37e33c7eff/cmh-2024-0359f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896d/11791572/4cb504e26474/cmh-2024-0359f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896d/11791572/1c045bb01298/cmh-2024-0359f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896d/11791572/75e669be69c4/cmh-2024-0359f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896d/11791572/5d94ad2556eb/cmh-2024-0359f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896d/11791572/9990e840e4ed/cmh-2024-0359f8.jpg

相似文献

1
Metabolic dysfunction-associated steatotic liver disease exhibits sex-specific microbial heterogeneity within intestinal compartments.代谢功能障碍相关脂肪性肝病在肠道各区域表现出性别特异性的微生物异质性。
Clin Mol Hepatol. 2025 Jan;31(1):179-195. doi: 10.3350/cmh.2024.0359. Epub 2024 Oct 11.
2
Microbiota Co-Metabolism Alterations Precede Changes in the Host Metabolism in the Early Stages of Diet-Induced MASLD in Wistar Rats.在饮食诱导的Wistar大鼠代谢相关脂肪性肝病(MASLD)早期阶段,微生物群共代谢改变先于宿主代谢变化。
Int J Mol Sci. 2025 Feb 2;26(3):1288. doi: 10.3390/ijms26031288.
3
A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease.HIV 和代谢功能障碍相关脂肪性肝病的肠道微生物组特征。
Front Immunol. 2023 Dec 14;14:1297378. doi: 10.3389/fimmu.2023.1297378. eCollection 2023.
4
HY7804 Modulates the Gut-Liver Axis to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease in a Mouse Model.HY7804调节肠-肝轴以改善小鼠模型中与代谢功能障碍相关的脂肪性肝病
Int J Mol Sci. 2025 Apr 10;26(8):3557. doi: 10.3390/ijms26083557.
5
COMPARISON OF GUT MICROBIOTA IN ALCOHOLIC AND METABOLIC-DYSFUNCION ASSOCIATED STEATOTIC LIVER DISEASE IN ANIMAL MODELS.酒精性和代谢相关脂肪性肝病动物模型中肠道微生物群的比较。
Arq Gastroenterol. 2024 Mar 15;61:e23100. doi: 10.1590/S0004-2803.24612023-100. eCollection 2024.
6
Characterization of gut dysbiosis and intestinal barrier dysfunction in patients with metabolic dysfunction-associated steatotic liver disease and chronic kidney disease: a comparative study.代谢功能障碍相关脂肪性肝病和慢性肾脏病患者肠道菌群失调及肠屏障功能障碍的特征:一项比较研究
Sci Rep. 2025 May 3;15(1):15481. doi: 10.1038/s41598-025-00237-6.
7
Alpha-aminobutyric acid ameliorates diet-induced metabolic dysfunction-associated steatotic liver disease (MASLD) progression in mice via enhancing AMPK/SIRT1 pathway and modulating the gut-liver axis.α-氨基丁酸通过增强AMPK/SIRT1通路和调节肠-肝轴改善饮食诱导的代谢功能障碍相关脂肪性肝病(MASLD)在小鼠中的进展。
J Nutr Biochem. 2025 Jun;140:109885. doi: 10.1016/j.jnutbio.2025.109885. Epub 2025 Feb 25.
8
Gut microbiota-based machine-learning signature for the diagnosis of alcohol-associated and metabolic dysfunction-associated steatotic liver disease.基于肠道微生物组的机器学习特征用于诊断酒精相关和代谢功能障碍相关脂肪性肝病。
Sci Rep. 2024 Jul 12;14(1):16122. doi: 10.1038/s41598-024-60768-2.
9
Duodenal-jejunal bypass ameliorates MASLD in rats by regulating gut microbiota and bile acid metabolism through FXR pathways.十二指肠-空肠旁路术通过FXR途径调节肠道微生物群和胆汁酸代谢来改善大鼠的非酒精性脂肪性肝炎。
Hepatol Commun. 2025 Jan 16;9(2). doi: 10.1097/HC9.0000000000000615. eCollection 2025 Feb 1.
10
Multi-omics analyses of the gut microbiota and metabolites in children with metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病患儿肠道微生物群和代谢物的多组学分析
mSystems. 2025 Apr 22;10(4):e0114824. doi: 10.1128/msystems.01148-24. Epub 2025 Mar 14.

引用本文的文献

1
Triglyceride-glucose-waist circumference index: A powerful tool for metabolic dysfunction-associated steatotic liver disease.甘油三酯-血糖-腰围指数:代谢功能障碍相关脂肪性肝病的有力工具。
World J Hepatol. 2025 Jul 27;17(7):107668. doi: 10.4254/wjh.v17.i7.107668.
2
Gut-Liver Axis: The Role of Intestinal Microbiota and Their Metabolites in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease.肠-肝轴:肠道微生物群及其代谢产物在代谢功能障碍相关脂肪性肝病进展中的作用
Gut Liver. 2025 May 8. doi: 10.5009/gnl240539.
3
Characteristics of serum bile acid profiles among individuals with metabolic dysfunction-associated steatotic liver disease.

本文引用的文献

1
Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.作者更正:雌激素受体-α与PNPLA3 p.I148M变体之间的相互作用驱动女性脂肪肝疾病易感性。
Nat Med. 2024 Apr;30(4):1212. doi: 10.1038/s41591-024-02817-x.
2
Sex differences in a mouse model of diet-induced obesity: the role of the gut microbiome.饮食诱导肥胖小鼠模型中的性别差异:肠道微生物组的作用。
Biol Sex Differ. 2024 Jan 10;15(1):5. doi: 10.1186/s13293-023-00580-1.
3
Diversity of the microbiota communities found in the various regions of the intestinal tract in healthy individuals and inflammatory bowel diseases.
代谢功能障碍相关脂肪性肝病患者血清胆汁酸谱特征
BMC Gastroenterol. 2025 May 5;25(1):334. doi: 10.1186/s12876-025-03903-1.
4
MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women.绝经后女性的代谢功能障碍相关脂肪性肝病:患病率、发病机制及基于性别的治疗方法
Biomedicines. 2025 Apr 2;13(4):855. doi: 10.3390/biomedicines13040855.
健康个体和炎症性肠病患者肠道不同部位微生物群落的多样性。
Front Immunol. 2023 Nov 2;14:1242242. doi: 10.3389/fimmu.2023.1242242. eCollection 2023.
4
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.雌激素受体-α与 PNPLA3 p.I148M 变异体的相互作用导致女性患脂肪肝疾病的易感性。
Nat Med. 2023 Oct;29(10):2643-2655. doi: 10.1038/s41591-023-02553-8. Epub 2023 Sep 25.
5
Sexual Dimorphism in Lipid Metabolism and Gut Microbiota in Mice Fed a High-Fat Diet.高脂饮食喂养的小鼠脂代谢和肠道微生物群的性别二态性。
Nutrients. 2023 May 2;15(9):2175. doi: 10.3390/nu15092175.
6
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家组关于新的脂肪肝疾病命名的德尔菲共识声明。
J Hepatol. 2023 Dec;79(6):1542-1556. doi: 10.1016/j.jhep.2023.06.003. Epub 2023 Jun 24.
7
The gut-liver axis and gut microbiota in health and liver disease.肠-肝轴与肠道微生物群在健康与肝病中的作用
Nat Rev Microbiol. 2023 Nov;21(11):719-733. doi: 10.1038/s41579-023-00904-3. Epub 2023 Jun 14.
8
MicrobiomeAnalyst 2.0: comprehensive statistical, functional and integrative analysis of microbiome data.微生物组分析家 2.0:全面的微生物组数据分析的统计、功能和综合分析。
Nucleic Acids Res. 2023 Jul 5;51(W1):W310-W318. doi: 10.1093/nar/gkad407.
9
Sex Difference is a Determinant of Gut Microbes and Their Metabolites SCFAs/MCFAs in High Fat Diet Fed Rats.性别差异是高脂肪饮食喂养大鼠肠道微生物及其代谢产物短链脂肪酸/中链脂肪酸的决定因素。
Curr Microbiol. 2022 Oct 8;79(11):347. doi: 10.1007/s00284-022-03025-x.
10
Gut-liver axis: Pathophysiological concepts and clinical implications.肠-肝轴:病理生理概念及临床意义。
Cell Metab. 2022 Nov 1;34(11):1700-1718. doi: 10.1016/j.cmet.2022.09.017. Epub 2022 Oct 7.